1376615-91-6
中文名稱
帕布昔利布雜質(zhì)E
英文名稱
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
CAS
1376615-91-6
分子式
C24H31N7O2
分子量
449.55
MOL 文件
1376615-91-6.mol
更新日期
2024/08/10 12:15:09
1376615-91-6 結(jié)構(gòu)式
基本信息
中文別名
帕博西尼雜質(zhì)M帕博西尼雜質(zhì)40
帕布昔利布雜質(zhì)5
帕布昔利布雜質(zhì)40
PALBOCICLIB雜質(zhì)4
PALBOCICLIB雜質(zhì)M
英文別名
Palbociclib-6Palbociclib Impurity E
Palbociclib Impurity 40
Palbociclib 1-?Hydroxyethyl
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
Palbociclib impurity 29/8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one
4-[6-(8-Cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino)-pyridin-3-yl]-piperazine-1-carboxylic acid tert-butyl ester
所屬類別
分析化學(xué)：藥典標(biāo)準(zhǔn)品和雜質(zhì)標(biāo)準(zhǔn)品應(yīng)用領(lǐng)域
用途一
Palbociclib 1-?Hydroxyethyl is an impurity of Palbociclib(P139900). Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.